leadf
logo-loader
viewPrecipio Inc
(
NASDAQ:PRPO
)

Precipio in talks with international health care systems to expand reach

Precipio Inc. (NASDAQ: PRPO) CEO Ilan Danieli tells Proactive Investors that the Connecticut-based diagnostics company is expanding internationally with its pathology services.

Danieli says the eight-year old company is already in talks with leading health care systems around the world, focusing first on Asia, South America, Europe, and the Middle East. In the past month, Precipio's stock has more than doubled, and Danieli says he believes the market is beginning to realize the company's value.

Quick facts: Precipio Inc

Follow
NASDAQ:PRPO

Price: 2.92 USD

Market Cap: $66.19 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Emmaus Life Sciences progressing with expanding availability of lead drug...

Emmaus Life Sciences Inc CEO Yutaka Niihara joined Proactive to discuss the Torrance, California-based group's focus on expanding its FDA approved drug, Endari, to treat sickle cell disease internationally, specifically focusing in on the Middle East. Niihara says recently, the National...

1 hour, 16 minutes ago

2 min read